VIVORYON Stock Was Up By 12.5% Today

(VIANEWS) – The Market ended the session with VIVORYON (VVY.AS) rising 12.5% to €0.51 on Monday while AEX-Index jumped 0.76% to €866.51. About VIVORYON Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta….

Read More